JULIA
ORIGÜEN SABATER
Profesora asociada de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (32)
2024
-
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324
2023
2022
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study
Transplant Infectious Disease, Vol. 24, Núm. 1
-
Early Treatment with Sotrovimab for Covid-19
The New England journal of medicine
2021
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2020
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
2019
-
Toxin B PCR amplification cycle threshold adds little to clinical variables for predicting outcomes in clostridium difficile infection: A retrospective cohort study
Journal of Clinical Microbiology, Vol. 57, Núm. 2
2018
-
Comparison of Predictors and Mortality between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Infection Control and Hospital Epidemiology, Vol. 39, Núm. 6, pp. 660-667
-
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test
Clinical Microbiology and Infection, Vol. 24, Núm. 4, pp. 414-421
-
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study
Transplant International, Vol. 31, Núm. 2, pp. 187-197
-
Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study
Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 985-991
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus
Infectious Diseases, Vol. 50, Núm. 11-12, pp. 837-846
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
Atherosclerosis, Vol. 269, pp. 204-210
-
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae
International Journal of Antimicrobial Agents, Vol. 52, Núm. 5, pp. 577-585
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19